Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Beatriz Moya Camacho
Real-World Safety of Treatment With Mepolizumab and Reslizumab in Patients With Severe Eosinophilic Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Related publications
Efficacy and Safety of Treatment With Biologicals (Benralizumab, Dupilumab, Mepolizumab, Omalizumab and Reslizumab) for Severe Eosinophilic Asthma
Allergy: European Journal of Allergy and Clinical Immunology
Allergy
Immunology
Pharmacoeconomic Analysis of Therapy With Reslizumab in Severe Eosinophilic Asthma
Pulmonologiya
Pulmonary
Respiratory Medicine
Real-World Effectiveness of Mepolizumab in Patients With Severe Asthma: An Examination of Exacerbations and Costs
Journal of Asthma and Allergy
Immunology
Pulmonary
Allergy
Respiratory Medicine
Patients With Severe Eosinophilic Asthma Treated With Mepolizumab: Results From Our Clinical Practice
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Assessment of the Long-Term Safety of Mepolizumab and Durability of Clinical Response in Patients With Severe Eosinophilic Asthma
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Prs55 - Cost-Effectiveness of Mepolizumab in Severe Eosinophilic Asthma Patients in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study
Clinical Therapeutics
Pharmacology
Reslizumab: Add-On Therapy for Severe Eosinophilic Asthma
Prescriber
Pharmacology
Therapeutic Switch From Omalizumab to Mepolizumab in Patients With Uncontrolled Severe Eosinophilic Asthma: Treatment Effect by Prior Omalizumab Treatment Duration
Journal of Allergy and Clinical Immunology
Allergy
Immunology
